CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...